David Larsen
Stock Analyst at BTIG
(0.19)
# 4,588
Out of 4,988 analysts
603
Total ratings
35%
Success rate
-4.4%
Average return
Main Sectors:
Stocks Rated by David Larsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CYRX Cryoport | Reiterated: Buy | $25 | $17.02 | +46.89% | 33 | Sep 18, 2026 | |
| OMDA Omada Health | Rated: Buy | $35 | $20.43 | +71.32% | 3 | Sep 11, 2026 | |
| DH Definitive Healthcare | Rated: Hold | n/a | $0.96 | - | 10 | Sep 3, 2026 | |
| HQY HealthEquity | Reiterated: Buy | $115 | $95.14 | +20.87% | 32 | Aug 28, 2026 | |
| MDLN Medline | Reiterated: Buy | $55 | $31.64 | +73.83% | 8 | Aug 27, 2026 | |
| VEEV Veeva Systems | Reiterated: Buy | $340 | $260.21 | +30.66% | 14 | Aug 26, 2026 | |
| HCAT Health Catalyst | Reiterated: Hold | n/a | $1.79 | - | 26 | Aug 19, 2026 | |
| HSIC Henry Schein | Reiterated: Buy | $100 → $110 | $84.84 | +29.66% | 16 | Aug 19, 2026 | |
| LFST LifeStance Health Group | Reiterated: Buy | $16 → $18 | $12.57 | +43.20% | 8 | Aug 19, 2026 | |
| DCGO DocGo | Reiterated: Hold | n/a | $0.3592 | - | 19 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $27.99 | - | 13 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 → $50 | $34.93 | +43.14% | 13 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $65 | $34.36 | +89.17% | 16 | Aug 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 | $19.85 | +76.32% | 16 | Aug 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $10 → $9 | $3.22 | +179.50% | 44 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $13.75 | - | 26 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $90 | $56.78 | +58.51% | 19 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $6.30 | - | 20 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 → $40 | $27.13 | +47.44% | 19 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $8 | $3.69 | +116.80% | 51 | Jul 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $6.96 | +29.31% | 12 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $19 | $18.44 | +0.33% | 18 | Jun 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $26.11 | - | 12 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $32.23 | - | 25 | Apr 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $266.42 | - | 11 | Feb 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $7.67 | - | 10 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $89.16 | - | 12 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 16 | Jun 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $308.78 | n/a | 11 | Aug 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $278.06 | n/a | 2 | Aug 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $88.84 | n/a | 28 | Aug 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $65 → $55 | $225.38 | n/a | 12 | Nov 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $17 → $9 | $0.8897 | n/a | 6 | Oct 31, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $170 → $160 | $874.65 | n/a | 11 | May 29, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $17 → $13 | $4.70 | n/a | 8 | Jun 19, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $9 | - | n/a | 3 | Nov 3, 2016 |
Cryoport
Sep 18, 2026
Reiterated: Buy
Price Target: $25
Current: $17.02
Upside: +46.89%
Omada Health
Sep 11, 2026
Rated: Buy
Price Target: $35
Current: $20.43
Upside: +71.32%
Definitive Healthcare
Sep 3, 2026
Rated: Hold
Price Target: n/a
Current: $0.96
Upside: -
HealthEquity
Aug 28, 2026
Reiterated: Buy
Price Target: $115
Current: $95.14
Upside: +20.87%
Medline
Aug 27, 2026
Reiterated: Buy
Price Target: $55
Current: $31.64
Upside: +73.83%
Veeva Systems
Aug 26, 2026
Reiterated: Buy
Price Target: $340
Current: $260.21
Upside: +30.66%
Health Catalyst
Aug 19, 2026
Reiterated: Hold
Price Target: n/a
Current: $1.79
Upside: -
Henry Schein
Aug 19, 2026
Reiterated: Buy
Price Target: $100 → $110
Current: $84.84
Upside: +29.66%
LifeStance Health Group
Aug 19, 2026
Reiterated: Buy
Price Target: $16 → $18
Current: $12.57
Upside: +43.20%
DocGo
Aug 18, 2026
Reiterated: Hold
Price Target: n/a
Current: $0.3592
Upside: -
Aug 11, 2026
Rated: Hold
Price Target: n/a
Current: $27.99
Upside: -
Aug 10, 2026
Reiterated: Buy
Price Target: $45 → $50
Current: $34.93
Upside: +43.14%
Aug 9, 2026
Reiterated: Buy
Price Target: $65
Current: $34.36
Upside: +89.17%
Aug 9, 2026
Reiterated: Buy
Price Target: $35
Current: $19.85
Upside: +76.32%
Aug 6, 2026
Rated: Buy
Price Target: $10 → $9
Current: $3.22
Upside: +179.50%
Aug 5, 2026
Reiterated: Hold
Price Target: n/a
Current: $13.75
Upside: -
Aug 3, 2026
Reiterated: Buy
Price Target: $90
Current: $56.78
Upside: +58.51%
Jul 29, 2026
Rated: Hold
Price Target: n/a
Current: $6.30
Upside: -
Jul 24, 2026
Reiterated: Buy
Price Target: $30 → $40
Current: $27.13
Upside: +47.44%
Jul 16, 2026
Rated: Buy
Price Target: $8
Current: $3.69
Upside: +116.80%
Jul 15, 2026
Reiterated: Buy
Price Target: $9
Current: $6.96
Upside: +29.31%
Jun 16, 2026
Rated: Hold
Price Target: $19
Current: $18.44
Upside: +0.33%
May 14, 2026
Downgraded: Hold
Price Target: n/a
Current: $26.11
Upside: -
Apr 28, 2026
Reiterated: Hold
Price Target: n/a
Current: $32.23
Upside: -
Feb 5, 2026
Reiterated: Hold
Price Target: n/a
Current: $266.42
Upside: -
Nov 14, 2025
Rated: Hold
Price Target: n/a
Current: $7.67
Upside: -
Nov 4, 2025
Rated: Hold
Price Target: n/a
Current: $89.16
Upside: -
Jun 23, 2023
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Aug 14, 2019
Rated: Hold
Price Target: n/a
Current: $308.78
Upside: n/a
Aug 14, 2019
Rated: Hold
Price Target: n/a
Current: $278.06
Upside: n/a
Aug 14, 2019
Rated: Hold
Price Target: n/a
Current: $88.84
Upside: n/a
Nov 16, 2018
Downgraded: Hold
Price Target: $65 → $55
Current: $225.38
Upside: n/a
Oct 31, 2018
Reiterated: Hold
Price Target: $17 → $9
Current: $0.8897
Upside: n/a
May 29, 2018
Reiterated: Hold
Price Target: $170 → $160
Current: $874.65
Upside: n/a
Jun 19, 2017
Downgraded: Hold
Price Target: $17 → $13
Current: $4.70
Upside: n/a
Nov 3, 2016
Reiterated: Hold
Price Target: $9
Current: -
Upside: n/a